Matches in SemOpenAlex for { <https://semopenalex.org/work/W191729897> ?p ?o ?g. }
Showing items 1 to 93 of
93
with 100 items per page.
- W191729897 endingPage "86" @default.
- W191729897 startingPage "379" @default.
- W191729897 abstract "Isolation and phenotypic characterization of tumor infiltrating lymphocytes (TILs) in some malignant tumors have been shown. TILs possess a good prognostic value as well as a therapeutic effect in these solid tumors. Our preliminary work shed some light on a good possibility of synthesis and secretion of specific protease enzyme system with a dimeric structure above 92 kDa for the lytic activity of TILs against breast tumor cells propagated ex vivo.This work aims at first isolation, activation and immuno-phenotypic characterization of TILs derived from malignant tumor tissues of breast cancer patients. Second, to optimize the conditions for the biological therapeutic efficiency of the identified TILs subpopulations as targeted cell therapy against breast cancer.The present work presented twelve patients with breast cancer from NCI, Cairo. Tcell isolation, activation, immunophenotyping and immunohistochemical investigations were performed. Enzymatic digestion method, mesh with pore size 355 & 45mm and flow cytometric analysis were used.The results revealed that, lymphocytes infiltrating the malignant tumor tissues were mainly of the Tcell type indicated by CD45RO positive markers as shown by immunohistochemical observations. The immunophenotypic analysis of the isolated TILs obtained from breast tumor tissues specimens and activated with interleukin- 2 (IL-2), showed that the ratio of CD4+/CD8+ was 0.89 which represents helper and cytotoxic sub-populations of TILs, respectively. Meanwhile, the ratio of CD4+/CD25+ was 16.03 representing the regulatory system of TILs subpopulation. In the peripheral blood of patients, the percentages of the CDs positive cells were different and the ratio of CD4+/CD8+ was 1.14+/-0.57 whereas the ratio of CD4+/CD25+ was 18.38+/-5.95. After mixing the isolated TILs and the T-lymphocytes obtained from the peripheral blood, the ratio of CD4+/CD8+ increased insignificantly to 1.45+/-0.67. Also the ratio of CD4+/CD25+ increased rough insignificantly, to 23.64+/-9.83.The isolated and identified TILs subpopulations have to be tested for their biological therapeutic efficacy first at ex-vivo level using the cr51 release assay; second at in-vivo level using experimental animal models as a sub-clinical investigation before going further to clinical study of using TILs as targeted bio-immunotherapy against human cancers.TILs - Immunohistochemistry - Immunophenotyping - Breast cancer." @default.
- W191729897 created "2016-06-24" @default.
- W191729897 creator A5013943779 @default.
- W191729897 creator A5022406977 @default.
- W191729897 creator A5035575768 @default.
- W191729897 creator A5040710476 @default.
- W191729897 creator A5055916837 @default.
- W191729897 creator A5084421375 @default.
- W191729897 creator A5091711158 @default.
- W191729897 date "2008-12-01" @default.
- W191729897 modified "2023-09-24" @default.
- W191729897 title "Isolation and Immuno-Phenotypic Characterization of Tumor Infiltrating Lymphocytes (TILs) Obtained from Breast Malignant Tumor Tissues of Egyptian Patients." @default.
- W191729897 cites W1228612998 @default.
- W191729897 cites W2054851015 @default.
- W191729897 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20571596" @default.
- W191729897 hasPublicationYear "2008" @default.
- W191729897 type Work @default.
- W191729897 sameAs 191729897 @default.
- W191729897 citedByCount "1" @default.
- W191729897 countsByYear W1917298972021 @default.
- W191729897 crossrefType "journal-article" @default.
- W191729897 hasAuthorship W191729897A5013943779 @default.
- W191729897 hasAuthorship W191729897A5022406977 @default.
- W191729897 hasAuthorship W191729897A5035575768 @default.
- W191729897 hasAuthorship W191729897A5040710476 @default.
- W191729897 hasAuthorship W191729897A5055916837 @default.
- W191729897 hasAuthorship W191729897A5084421375 @default.
- W191729897 hasAuthorship W191729897A5091711158 @default.
- W191729897 hasConcept C104317684 @default.
- W191729897 hasConcept C121608353 @default.
- W191729897 hasConcept C126322002 @default.
- W191729897 hasConcept C127716648 @default.
- W191729897 hasConcept C142724271 @default.
- W191729897 hasConcept C167672396 @default.
- W191729897 hasConcept C196166836 @default.
- W191729897 hasConcept C203014093 @default.
- W191729897 hasConcept C204232928 @default.
- W191729897 hasConcept C2778326572 @default.
- W191729897 hasConcept C502942594 @default.
- W191729897 hasConcept C530470458 @default.
- W191729897 hasConcept C553184892 @default.
- W191729897 hasConcept C55493867 @default.
- W191729897 hasConcept C71924100 @default.
- W191729897 hasConcept C86803240 @default.
- W191729897 hasConcept C8891405 @default.
- W191729897 hasConceptScore W191729897C104317684 @default.
- W191729897 hasConceptScore W191729897C121608353 @default.
- W191729897 hasConceptScore W191729897C126322002 @default.
- W191729897 hasConceptScore W191729897C127716648 @default.
- W191729897 hasConceptScore W191729897C142724271 @default.
- W191729897 hasConceptScore W191729897C167672396 @default.
- W191729897 hasConceptScore W191729897C196166836 @default.
- W191729897 hasConceptScore W191729897C203014093 @default.
- W191729897 hasConceptScore W191729897C204232928 @default.
- W191729897 hasConceptScore W191729897C2778326572 @default.
- W191729897 hasConceptScore W191729897C502942594 @default.
- W191729897 hasConceptScore W191729897C530470458 @default.
- W191729897 hasConceptScore W191729897C553184892 @default.
- W191729897 hasConceptScore W191729897C55493867 @default.
- W191729897 hasConceptScore W191729897C71924100 @default.
- W191729897 hasConceptScore W191729897C86803240 @default.
- W191729897 hasConceptScore W191729897C8891405 @default.
- W191729897 hasIssue "4" @default.
- W191729897 hasLocation W1917298971 @default.
- W191729897 hasOpenAccess W191729897 @default.
- W191729897 hasPrimaryLocation W1917298971 @default.
- W191729897 hasRelatedWork W2000293051 @default.
- W191729897 hasRelatedWork W2020435548 @default.
- W191729897 hasRelatedWork W2044767252 @default.
- W191729897 hasRelatedWork W2131626997 @default.
- W191729897 hasRelatedWork W2145068212 @default.
- W191729897 hasRelatedWork W2209120434 @default.
- W191729897 hasRelatedWork W2350366207 @default.
- W191729897 hasRelatedWork W2381725807 @default.
- W191729897 hasRelatedWork W2493436472 @default.
- W191729897 hasRelatedWork W2551454550 @default.
- W191729897 hasRelatedWork W2600212560 @default.
- W191729897 hasRelatedWork W2605873772 @default.
- W191729897 hasRelatedWork W2747658619 @default.
- W191729897 hasRelatedWork W2981817124 @default.
- W191729897 hasRelatedWork W2999889310 @default.
- W191729897 hasRelatedWork W3031458515 @default.
- W191729897 hasRelatedWork W3099210300 @default.
- W191729897 hasRelatedWork W3176889573 @default.
- W191729897 hasRelatedWork W3199786216 @default.
- W191729897 hasRelatedWork W2960815422 @default.
- W191729897 hasVolume "20" @default.
- W191729897 isParatext "false" @default.
- W191729897 isRetracted "false" @default.
- W191729897 magId "191729897" @default.
- W191729897 workType "article" @default.